Published on : Apr 20, 2018
Albany, New York, April 20, 2018: The nose, sinus, throat, bronchi and lungs are the most frequent sites of contagious illness. Almost every second person visiting the clinic has had some kind of cold related issue. A new study, focusing on United States market for cough, cold and allergy remedies has been broadcasted to the wide database of Market Research Hub (MRH), which is titled as “Cough, Cold, Flu and Allergy Remedies-US-April 2018”. The study offers comprehensive analysis and forecast on the future direction of this market. A profiling of key companies operating in this sector is also offered to readers. According to the research key findings, strong flu season drives industry growth in 2017-18.
Presently, cough, cold, and flu illnesses are widespread in United States. Therefore, there has been increasing awareness to cure the illness. Ailment sufferers are seeking easy and effective remedies. The research finds that environment variation could alter allergy treatment tactics. Also, rising pet ownership could increase allergy sufferers, and remedy demand.
Report Inclusion and Key Findings
The research provides 360-degree view of the cinemas market in the US by examining market dynamics, analyzing trends and understanding consumer attitudes towards specifically cough, cold, flu and allergy remedies in the UK. The report begins with in-depth market overview and executive summary sharing key details with market-related data such as issues and insights, market size and forecast value and volume until the end of 2022, market segmentation, and competitiveness.
As per the active research evaluations, total sales for the cough, cold, flu, and allergy remedy market reached $9.5 billion in 2017, a 6.2% increase from 2016. The future will see steady growth in the coming years. As per the consumer perspective, the report adds that the majority of consumers have experienced an ailment within the past 12 months, and seek easy-to-use, accessible, and effective remedies, mainly OTC medications to treat the cold and flu symptoms.
In the present time, consumer trust raised offerings drive private label growth. Private label, naturally-positioned remedies outperform Private label and natural remedies are showing heightened growth, while consumers are prioritizing value and convenience when shopping for ailment remedies. Apart from that natural remedies influence broader trends, and experience growth. The start to a record-breaking flu season has already driven an 8.7% increase in the cold and sinus remedies segment, fueled by sales of flagship, multi-functional brands such as Mucinex, Vicks, and Tylenol.
Another vital section of the report is competitive landscape featuring some of the top companies, their products and business strategies, and their standing in the U.S. Market. As per the research, Reckitt Benckiser leads market with Mucinex brand, while Bayer, Johnson & Johnson vie for second place. Additionally, Vicks brand drives P&G sales and market share gains.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1714453
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com